Abstract
Stromal cell-derived factor 1-alpha (SDF) is a potent bone marrow chemokine capable of recruiting circulating progenitor populations to injured tissue. SDF has known angiogenic capabilities, but bone marrow-derived cellular contributions to tissue regeneration remain controversial. Bone marrow from DsRed-transgenic donors was transplanted into recipients to lineage-trace circulating cells after myocardial infarction (MI). SDF was delivered post-MI, and hearts were evaluated for recruitment and plasticity of bone marrow-derived populations. SDF treatment improved ventricular function, border zone vessel density, and CD31+ cell frequency post-MI. Bone marrow-derived endothelial cells were observed; these cells arose through both cell fusion and transdifferentiation. Circulating cells also adopted cardiomyocyte fates, but such events were exceedingly rare and almost exclusively resulted from cell fusion. SDF did not significantly alter the proportion of circulating cells that adopted non-hematopoietic fates. Mechanistic insight into the governance of circulating cells is essential to realizing the full potential of cytokine therapies.
Similar content being viewed by others
Abbreviations
- MI:
-
Myocardial infarction
- SDF:
-
Stromal cell-derived factor 1-alpha
References
Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763–776.
Laugwitz, K.-L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S., et al. (2005). Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 433(7026), 647–653. https://doi.org/10.1038/nature03215.
Oh, H., Bradfute, S. B., Gallardo, T. D., Nakamura, T., Gaussin, V., Mishina, Y., et al. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences of the United States of America, 100(21), 12313–12318. https://doi.org/10.1073/pnas.2132126100.
Smart, N., Bollini, S., Dubé, K. N., Vieira, J. M., Zhou, B., Davidson, S., et al. (2011). De novo cardiomyocytes from within the activated adult heart after injury. Nature, 474(7353), 640–644. https://doi.org/10.1038/nature10188.
Macarthur, J. W., Cohen, J. E., McGarvey, J. R., Shudo, Y., Patel, J. B., Trubelja, A., et al. (2014). Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model. Circulation Research, 114(4), 650–659. https://doi.org/10.1161/CIRCRESAHA.114.302884.
Chung, E. S., Miller, L., Patel, A. N., Anderson, R. D., Mendelsohn, F. O., Traverse, J., et al. (2015). Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized phase II trial. European Heart Journal, 36(33), 2228–2238. https://doi.org/10.1093/eurheartj/ehv254.
Balsam, L. B., Wagers, A. J., Christensen, J. L., Kofidis, T., Weissman, I. L., & Robbins, R. C. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 428(6983), 668–673. https://doi.org/10.1038/nature02460.
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829), 701–705. https://doi.org/10.1038/35070587.
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., et al. (2004). Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Medicine, 10(5), 494–501. https://doi.org/10.1038/nm1040.
Mouquet, F., Pfister, O., Jain, M., Oikonomopoulos, A., Ngoy, S., Summer, R., et al. (2005). Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circulation Research, 97(11), 1090–1092. https://doi.org/10.1161/01.RES.0000194330.66545.f5.
Wu, J. M. F., Hsueh, Y.-C., Ch’ang, H.-J., Luo, C.-Y., Wu, L.-W., Nakauchi, H., & Hsieh, P. C. H. (2015). Circulating cells contribute to cardiomyocyte regeneration after injury. Circulation Research, 116(4), 633–641. https://doi.org/10.1161/CIRCRESAHA.116.304564.
Wagers, A. J., Sherwood, R. I., Christensen, J. L., & Weissman, I. L. (2002). Little evidence for developmental plasticity of adult hematopoietic stem cells. Science, 297(5590), 2256–2259. https://doi.org/10.1126/science.1074807.
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. The Journal of Clinical Investigation, 107(11), 1395–1402. https://doi.org/10.1172/JCI12150.
van Ramshorst, J., Bax, J. J., Beeres, S. L. M. A., Dibbets-Schneider, P., Roes, S. D., Stokkel, M. P. M., et al. (2009). Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. The Journal of the American Medical Association, 301(19), 1997–2004. https://doi.org/10.1001/jama.2009.685.
Traverse, J. H., Henry, T. D., Ellis, S. G., Pepine, C. J., Willerson, J. T., Zhao, D. X. M., et al. (2011). Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. The Journal of the American Medical Association, 306(19), 2110–2119. https://doi.org/10.1001/jama.2011.1670.
Strauer, B. E., Brehm, M., Zeus, T., Köstering, M., Hernandez, A., Sorg, R. V., et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106(15), 1913–1918. https://doi.org/10.1161/01.CIR.0000034046.87607.1C.
Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1210–1221. https://doi.org/10.1056/NEJMoa060186.
Tendera, M., Wojakowski, W., Ruzyłło, W., Chojnowska, L., Kepka, C., Tracz, W., et al. (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) trial. European Heart Journal, 30(11), 1313–1321. https://doi.org/10.1093/eurheartj/ehp073.
Bartunek, J., Vanderheyden, M., Vandekerckhove, B., Mansour, S., De Bruyne, B., De Bondt, P., et al. (2005). Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation, 112(9 Suppl), I178–I183. https://doi.org/10.1161/CIRCULATIONAHA.104.522292.
Ascheim, D. D., Gelijns, A. C., Goldstein, D., Moye, L. A., Smedira, N., Lee, S., et al. (2014). Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation, 129(22), 2287–2296. https://doi.org/10.1161/CIRCULATIONAHA.113.007412.
Vintersten, K., Monetti, C., Gertsenstein, M., Zhang, P., Laszlo, L., Biechele, S., & Nagy, A. (2004). Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis, 40(4), 241–246. https://doi.org/10.1002/gene.20095.
Hiesinger, W., Brukman, M. J., McCormick, R. C., Fitzpatrick, J. R., Frederick, J. R., Yang, E. C., et al. (2012). Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model. The Journal of Thoracic and Cardiovascular Surgery, 143(4), 962–966. https://doi.org/10.1016/j.jtcvs.2011.12.028.
Woo, Y. J., Grand, T. J., Berry, M. F., Atluri, P., Moise, M. A., Hsu, V. M., et al. (2005). Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. The Journal of Thoracic and Cardiovascular Surgery, 130(2), 321–329. https://doi.org/10.1016/j.jtcvs.2004.11.041.
Czechowicz, A., Kraft, D., Weissman, I. L., & Bhattacharya, D. (2007). Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science, 318(5854), 1296–1299. https://doi.org/10.1126/science.1149726.
Saxena, A., Fish, J. E., White, M. D., Yu, S., Smyth, J. W. P., Shaw, R. M., et al. (2008). Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation, 117(17), 2224–2231. https://doi.org/10.1161/CIRCULATIONAHA.107.694992.
Hiesinger, W., Perez-Aguilar, J. M., Atluri, P., Marotta, N. A., Frederick, J. R., Fitzpatrick, J. R., et al. (2011). Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog. Circulation, 124(11 Suppl), S18–S26. https://doi.org/10.1161/CIRCULATIONAHA.110.009431.
MacArthur, J. W., Purcell, B. P., Shudo, Y., Cohen, J. E., Fairman, A., Trubelja, A., et al. (2013). Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction. Circulation, 128(11 Suppl 1), S79–S86. https://doi.org/10.1161/CIRCULATIONAHA.112.000343.
Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Nakajima, H. O., Rubart, M., et al. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428(6983), 664–668. https://doi.org/10.1038/nature02446.
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., et al. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research, 85(3), 221–228.
Huang, Y., Mao, Q., He, J., Su, J., Peng, Y., Liang, W., et al. (2017). Fusions of tumor-derived endothelial cells with dendritic cells induces antitumor immunity. Scientific Reports, 7, 46544. https://doi.org/10.1038/srep46544.
Fantin, A., Vieira, J. M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., et al. (2010). Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood, 116(5), 829–840. https://doi.org/10.1182/blood-2009-12-257832.
Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., et al. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 425(6961), 968–973. https://doi.org/10.1038/nature02069.
Senyo, S. E., Steinhauser, M. L., Pizzimenti, C. L., Yang, V. K., Cai, L., Wang, M., et al. (2013). Mammalian heart renewal by pre-existing cardiomyocytes. Nature, 493(7432), 433–436. https://doi.org/10.1038/nature11682.
Kimura, W., Xiao, F., Canseco, D. C., Muralidhar, S., Thet, S., Zhang, H. M., et al. (2015). Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart. Nature, 523(7559), 226–230. https://doi.org/10.1038/nature14582.
Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. The Lancet, 362(9385), 697–703. https://doi.org/10.1016/S0140-6736(03)14232-8.
Sundararaman, S., Miller, T. J., Pastore, J. M., Kiedrowski, M., Aras, R., & Penn, M. S. (2011). Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Therapy, 18(9), 867–873. https://doi.org/10.1038/gt.2011.18.
Ascione, R., Rowlinson, J., Avolio, E., Katare, R., Meloni, M., Spencer, H. L., et al. (2015). Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction. Stem Cell Research & Therapy, 6, 53. https://doi.org/10.1186/s13287-015-0028-y.
Funding
This work was supported by the National Institutes of Health [R01 HL089315-01 to Y.J.W., S10OD010344-01A1 to Stanford Center for In Vivo Imaging] and the American Heart Association [14POST20380744 to A.B.G.]
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human Subjects/Animal Subjects Statement
No human studies were carried out by the authors for this article. All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
Conflict of Interest
Andrew B. Goldstone, MD, PhD; Jeffery E. Cohen, MD; and Y. Joseph Woo, MD are co-authors on the US patent application number 15/136,612. The remaining authors have no conflicts of interest.
Additional information
Associate Editor Joost Sluijter oversaw the review of this article
Electronic supplementary material
ESM 1
(PDF 250 kb)
Rights and permissions
About this article
Cite this article
Goldstone, A.B., Burnett, C.E., Cohen, J.E. et al. SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells. J. of Cardiovasc. Trans. Res. 11, 274–284 (2018). https://doi.org/10.1007/s12265-017-9772-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-017-9772-y